The Cooper Companies, Inc. $COO Shares Acquired by DAVENPORT & Co LLC

DAVENPORT & Co LLC lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1,359.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 567,203 shares of the medical device company’s stock after buying an additional 528,346 shares during the period. DAVENPORT & Co LLC owned 0.29% of Cooper Companies worth $46,642,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Capital World Investors grew its holdings in shares of Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after purchasing an additional 2,159,233 shares during the last quarter. State Street Corp lifted its holdings in shares of Cooper Companies by 1.2% in the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock worth $616,227,000 after purchasing an additional 104,910 shares during the last quarter. Wellington Management Group LLP boosted its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the period. Sustainable Growth Advisers LP boosted its position in Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after purchasing an additional 747,476 shares during the period. Finally, Ameriprise Financial Inc. grew its stake in Cooper Companies by 98.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after buying an additional 1,683,561 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Robert W. Baird increased their target price on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. Morgan Stanley boosted their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Mizuho set a $100.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a report on Friday, December 5th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research report on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $90.79.

Key Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Q1 results and near‑term guidance: Cooper reported an EPS beat ($1.10 vs. $1.03 consensus) and revenue roughly in line with expectations; management set Q2 2026 EPS guidance of $4.58–$4.66, supporting the growth story and underwriting the stock’s near‑term strength. (Background: market cap ~ $13.8B, P/E ~34.9, PEG ~1.8)
• Positive Sentiment: Bullish analyst/press coverage: Zacks published pieces highlighting COO as an attractive growth stock and listing reasons growth investors shouldn’t overlook the company — these positive narratives can attract momentum buyers and help sentiment. 3 Reasons Why Growth Investors Shouldn’t Overlook The Cooper Companies (COO)
• Positive Sentiment: Additional Zacks coverage reiterates COO’s top‑ranked growth characteristics, which can reinforce buy-side interest and analyst attention. The Cooper Companies (COO) is a Top-Ranked Growth Stock: Should You Buy?
• Neutral Sentiment: Short‑interest data appears inconsistent/erroneous: multiple reports show “0 shares” shorted and 0.0 days to cover with NaN changes — this looks like a data glitch and provides no reliable signal on bearish positioning.
• Neutral Sentiment: Unrelated market headlines (crypto, other companies): broader media items — e.g., Tether planning a Big Four audit and press on unrelated companies (Cooper‑Standard, Bass Oil, HC Group) — likely have little direct impact on COO’s fundamentals. Tether says ‘Big Four‘ firm to handle first audit of USDT reserves
• Negative Sentiment: Technical/volume caution: the stock is trading below its 50‑day (~$79.71) and 200‑day (~$76.15) moving averages and today’s volume is below average — these factors suggest the intraday uptick may lack broad conviction and could limit near‑term upside until technicals improve.

Cooper Companies Stock Up 0.4%

Shares of Cooper Companies stock opened at $70.49 on Wednesday. The business’s fifty day moving average price is $79.49 and its two-hundred day moving average price is $76.16. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a market capitalization of $13.75 billion, a P/E ratio of 34.90, a PEG ratio of 1.81 and a beta of 1.02. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.03 by $0.07. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.